Jacobs Solutions (J) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.37 per share a year ago.
J's Q4 results are likely to reflect gains from record backlog and strong demand across key sectors.
Jacobs Solutions (J) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
J wins major NYSDOT project to modernize New York's highways and bridges.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Jacobs Solutions is a Buy due to its successful business transformation, focus on high-growth sectors, and strong external growth drivers like IIJA and CHIPS Act. Record backlog, rising margins, and aggressive capital returns (buybacks and dividend hikes) underscore management's confidence and support double-digit EPS growth. Valuation remains attractive: shares trade at a discount to fair value, with DCF and multiples analysis pointing to 12-15% upside and a $165 price target.
J lands a program manager role for a major Dallas pediatric hospital project with Children's Health and UT Southwestern.
Jacobs Solutions Inc. (NYSE:J ) Q3 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Bert Subin - Senior Vice President of Investor Relations Robert V. Pragada - CEO & Chair of the Board Venkatesh R.
J posts Q3 EPS beat on strong infrastructure demand and raises FY25 EPS view, despite revenue miss and FX pressures.
While the top- and bottom-line numbers for Jacobs Solutions (J) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Jacobs Solutions (J) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.96 per share a year ago.
Jacobs' Q3 earnings are likely to slide 20% amid macro pressures and funding delays, despite rising sector demand and cost control efforts.